Glucose Health, Inc. Fiscal 2022 Annual Report
Glucose Health, Inc. (OTC PINK:GLUC) reported strong fiscal 2022 results, achieving over $1 million in annual revenue for the first time, totaling $1,072,655, a 12% increase from $953,681 in 2021. The company also saw gross profits rise 11% to $456,715. With zero debt and minimal liabilities, GLUC continues as an emerging growth company. The successful launch of GLUCODOWN® flavors, available on Amazon and CVS, supports this growth. In 2023, Glucose Health plans to expand its distribution and launch new brands like FIBER UP® and be rite®. The company maintains a strong online and in-store presence with positive customer feedback.
- Fiscal 2022 revenue reached $1,072,655, marking a 12% year-on-year increase.
- Gross profit increased by 11% to $456,715 despite cost pressures.
- No debt and de minimis liabilities strengthen the company's financial position.
- Successful sales of GLUCODOWN® flavors on Amazon with an extensive product range.
- None.
BENTONVILLE, AR / ACCESSWIRE / March 23, 2023 / Glucose Health, Inc. (OTC PINK:GLUC) ("Company") is pleased to highlight selected financial metrics presented in its Annual Report posted today at OTCMarkets.com. For fiscal 2022, Glucose Health, Inc. surpassed
- Fiscal 2022 Revenue of
$1,072,655 vs.$953,681 for Fiscal 2021 = a12% increase - Fiscal 2022 Gross Profit of
$456,715 vs.$410,042 = an11% increase - Fiscal 2022 Total Debt of -0-
- 19,638,632 shares (fully diluted)
During fiscal 2022, eight flavors of GLUCODOWN® Blood Sugar Maintenance were variously shipped to Amazon. These included GLUCODOWN® Cherry, Peach Mango, Strawberry Banana and Watermelon drink mix flavors, first introduced at Amazon in mid 2021, and GLUCODOWN® Peach, Lemon, Raspberry and Super Berry iced tea mix flavors, first introduced at Amazon in late 2017. As in previous fiscal years, all shipments of GLUCODOWN® to Amazon sell-out. At no time did the inventory age of GLUCODOWN® at Amazon exceed 90 days in fiscal 2022.
Presently eighteen different GLUCODOWN® items, including singles, double-packs and variety packs, are stocked at the GLUCODOWN® Amazon store (www.amazon.com/glucodown). Two of eighteen GLUCODOWN® items are 5 stars, fifteen of eighteen items are 4.5 stars and one item is 4 stars. In addition to online at Amazon, three GLUCODOWN® iced tea mix flavors (Peach, Lemon and Raspberry) are also stocked in-store at CVS Pharmacy Health Hub locations. GLUCODOWN® has maintained its in-store shelf presence at all CVS Pharmacy Heath Hub locations since fiscal 2020.
For fiscal 2023, Glucose Health, Inc. will endeavor to maintain serving GLUCODOWN® customers at Amazon and CVS. The Company will additionally continue its efforts to source growth capital for the purposes of expanding GLUCODOWN® distribution and to launch its innovative new brands FIBER UP® - a delicious drink mix to be available in on-the-go stick packs and formulated to support the 5 markers of metabolic health- and be rite® - a full-flavor, soluble fiber and micronutrient infused ready-to-drink beverage - the first of its kind in North America.
About Glucose Health, Inc. (OTC PINK:GLUC)
Glucose Health, Inc. specializes in producing healthy and delicious soluble fiber beverages, nutritionally appropriate 1 for the nation's 100+ million 2 pre and Type-2 diabetics. Additionally in 2023, the Company plans to launch two new soluble fiber infused healthy and delicious beverage brands, FIBER UP® and be rite® marketed to widely to health-conscious consumers. Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC: GLUC.
To purchase GLUCODOWN® visit www.glucodown.com
1 For citations visit www.glucodown.com/clinical-data
2 National Diabetes Statistics Review, 2020 ; Centers for Disease Control and Prevention, Department of Health and Human Services
Contact:
Murray Fleming
Glucose Health, Inc.
info@glucosehealthinc.com
(479) 802-3827
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and while Glucose Health, Inc. is not subject to the 1934 Securities and Exchange Act, contains forward-looking statements within the meaning Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential, "possible," "probable, "believes," "seeks," "may, "will, "should," "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.
SOURCE: Glucose Health, Inc.
View source version on accesswire.com:
https://www.accesswire.com/745586/Glucose-Health-Inc-Fiscal-2022-Annual-Report
FAQ
What were the fiscal 2022 earnings results for Glucose Health, Inc. (GLUC)?
What is Glucose Health's growth strategy for 2023?
How did Glucose Health perform financially in 2022?